Trump Uses Tic Tacs at Rally to Talk Economic Strategy 

Donald Trump has held another press conference and accused Kamala Harris of lacking coherent policy. He also complained that the Vice President had stolen his no-tax-on-tips policy and said he would not announce details of his own proposals to prevent the Harris team from copying them. 

The former President attacked Harris’s lack of a solution to America’s cost-of-living increases, saying people were only getting “half a deal” at the grocery store. However, as he spoke, inflation dropped to 2.9%—its lowest level since 2021. To illustrate what he called Harris’s economic incompetence, Trump took two boxes of Tic Tacs from his pocket and used them to demonstrate inflation. He explained that the larger box had turned into the smaller one. 

During the 80-minute press conference, Mr. Trump also accused the Vice President of launching personal attacks on him, adding that he is “entitled” to retaliate. He railed that Harris called him “weird” and said it was she and her running mate who were really “weird.” The former President dismissed a reporter’s question about whether personal attacks on Harris were helpful and said, “I have to do it my way.” 

Commentators have largely described Trump’s latest address to reporters as another potential liability to his campaign. He repeated many of the statements that have drawn criticism even from some Republicans. For instance, Trump suggested that Joe Biden would turn up at the Democratic convention in Chicago and demand to be the party’s candidate again. He also insisted his crowd sizes are bigger than Harris’s and claimed Americans didn’t even know her name. 

Meanwhile, Joe Biden appeared at a Kamala Harris rally for the first time. Speaking to a crowd in Maryland, the President focused on legislation that allowed Medicare to negotiate prices with drug companies for the first time. The Biden administration earlier announced that ten different medicines had been reduced in price thanks to the new law, including the diabetes drug Jardiance, which dropped from $593 to $197.